Table 1.

Summary of 3-day energy intake record by IBS patients before sample collection ^a and IBS patients’ body weight measurements. Patient data from samples included in the ¹H-NMR study.

Nutrient	GDL milk product b	Probiotic milk product c
Energy, kJ/(kg body wt) d
Baseline	31.07 ± 1.57	28.25 ± 1.50
Post treatment	27.78 ± 1.86 *	24.24 ± 1.25 *
Protein, g/(kg body wt)
Baseline	1.22 ± 0.08	1.12 ± 0.05
Post treatment	1.04 ± 0.07 *	0.95 ± 0.04 *
Fat, g/(kg body wt)
Baseline	1.21 ± 0.09	1.04 ± 0.07
Post treatment	0.98 ± 0.09 *	0.89 ± 0.05 *
Carbohydrates, g/(kg body wt)
Baseline	3.62 ± 0.18	3.34 ± 0.19
Post treatment	3.31 ± 0.23 *	2.89 ± 0.19 *
Calcium, mg/(kg body wt)
Baseline	16.06 ± 1.19	13.71 ± 1.14
Post treatment	12.68 ± 1.24 *	10.07 ± 1.00 *
Fiber, g/(kg body wt)
Baseline	0.31 ± 0.02	0.26 ± 0.01
Post treatment	0.26 ± 0.03 *	0.21 ± 0.01 *
Weight, kg
Baseline	73.13 ± 2.58	72.17 ± 2.74
Post treatment	74.11 ± 2.75 *	72.51 ± 2.74

^a Nutritional data are given as mean ± SEM of summed 3-day nutritional intake. Baseline data was obtained 1 day before initiation of the intervention period and post treatment data was collected on the last day of the intervention period. Body weight measurements are given as mean ± SEM. Post treatment means marked with * differ significantly from baseline (P ≤ 0.05);

^b n = 28. One patient failed to record nutritional data before collection of the baseline sample and was therefore left out of the analysis;

^c n = 29. One patient failed to record nutritional data before collection of the post treatment sample and was therefore left out of the analysis;

^d Patient energy intake at baseline and post treatment differed not significantly (P > 0.05) between GDL milk product and probiotic milk product patient groups.